BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: monoclonal antibodies
1
Crosstalk between gut microbiota and COVID-19 impacts pancreatic cancer progression
8/10/2022 1:14:37 PM | Browse: 368 | Download: 847
2
Historical evolution, overview, and therapeutic manipulation of co-stimulatory molecules
1/21/2022 9:46:26 AM | Browse: 324 | Download: 673
3
Interleukin 12/interleukin 23 pathway: Biological basis and therapeutic effect in patients with Crohn's disease
9/25/2018 3:44:36 AM | Browse: 739 | Download: 863
4
Present and future of metastatic colorectal cancer treatment: A review of new candidate targets
7/12/2017 6:45:23 AM | Browse: 950 | Download: 1476
5
Mechanisms of resistance to anti-epidermal growth factor receptor inhibitors in metastatic colorectal cancer
7/22/2016 1:36:00 PM | Browse: 1064 | Download: 1299
6
On deaf ears, Mycobacterium avium paratuberculosis in pathogenesis Crohn’s and other diseases
12/24/2015 11:11:00 AM | Browse: 985 | Download: 1485
7
Monoclonal antibodies: Principles and applications of immmunodiagnosis and immunotherapy for hepatitis C virus
10/2/2015 7:07:00 PM | Browse: 1208 | Download: 1528
8
Safety of biologic therapies during pregnancy in women with rheumatic disease
7/8/2015 9:04:00 AM | Browse: 1143 | Download: 1520
9
Gastric cancer and the epoch of immunotherapy approaches
5/20/2015 5:01:00 PM | Browse: 1099 | Download: 1560
10
Clinical management of advanced gastric cancer: The role of new molecular drugs
10/29/2014 7:34:00 PM | Browse: 1479 | Download: 1214
11
Steroid-refractory ulcerative colitis and associated primary sclerosing cholangitis treated with infliximab
9/16/2014 6:10:00 PM | Browse: 1070 | Download: 764
12
Monoclonal antibodies that target the immunogenic proteins expressed in colorectal cancer
8/26/2014 4:48:00 PM | Browse: 828 | Download: 629
13
Spontaneous free perforation of the small intestine in adults
8/25/2014 2:47:00 PM | Browse: 1115 | Download: 737
Write to the Help Desk
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345